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Two fixation sites for penicilloyl groups on human albumin were demonstrated. Using CNBr cleavage the 
first site was located between methionine 123 and methionine 297 and the second one between methionine 
297 and the C-terminal residue. In both cases, penicilloyl groups were unmasked by pronase degradation 
or disulfide bond reduction. 
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1. INTRODUCTION 
Bisalbuminemia due to the presence of a fast 
albumin component was observed in patients 
receiving large amounts of penicillin [ 11. This tran- 
sient bisalbuminemia was shown to be due to the 
presence of penicilloyl groups on fast albumin [2]. 
In this work the location of penicilloyl sites within 
fragments obtained by CNBr cleavage is reported. 
2. MATERIALS AND METHODS 
Benzylpenicillin sodium and penicilloyl E- 
aminocaproate (PtAC) were from Specia. 
Crystallized human serum albumin (HSA), 
100% pure by electrophoresis, was purchased from 
Mann. Crystallized ovalbumin (OVA), 100% pure, 
was obtained from Sigma. After dialysis against 
water the two proteins were lyophilized. 
Penicilloylated ovalbumin (POVA) was pre- 
pared by the same procedure as used by Wal et al. 
[3] for preparing penicilloylated bovine y-globulin. 
POVA was partly insoluble and centrifuged before 
use. 
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Serum was collected from a patient receiving in- 
travenously 50 x lo6 IU of penicillin G per day for 
40 days. Three successive samples were collected at 
1 week intervals at the end of the treatment. The 
samples were mixed and normal and fast albumin 
were prepared by chromatography on DEAE- 
Sephadex as described by Lapresle and Wal [2]. 
CNBr fragments of fast albumin were prepared 
as specified by Lapresle and Doyen [4]. The reduc- 
tion of the fragments with ,8-mercaptoethanol was 
carried out according to Crestfield et al. [5]. 
Pronase B grade, the bacterial protease from 
Streptomyces griseus, was obtained from 
Calbiochem. Degradation of albumin or its 
fragments with this enzyme was performed as 
reported by Lapresle and Wal [2]. 
Alkaline phosphatase (AP) from Escherichia 
cofi was obtained from Sigma. Penicilloylated 
alkaline phosphatase (PAP) was prepared as 
described by Lapresle and Lafaye [6]. The number 
of penicilloyl groups per molecule of AP, 
measured by RIA, was equal to 0.5. 
Anti-penicilloyl antibodies were raised in rabbits 
with bovine y-globulin coupled to penicillin as 
described by Wal et al. [3]. Two immunoad- 
sorbents were prepared by reacting 1 g of 
Sepharose 4B with either 10 mg POVA or 10 mg 
HSA following the recommendations of the 
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manufacturer (Pharmacia). Antibodies were 
isolated from the serum by fixation on and elution 
from the immunoadsorbent prepared with POVA. 
Further purification was achieved by filtering an- 
tibody solution through an immunoadsorbent 
prepared with HSA. The nonadsorbed fraction 
was collected, dialysed against 0.15 M NaCl and 
kept frozen. 
PAP and anti-penicilloyl antibodies were used 
for an enzyme-linked immunosorbent assay 
described by Lapresle and Lafaye [6]. A reference 
inhibition curve for the reaction between PAP and 
anti-penicilloyl antibodies was established with 
PcAC. Penicilloyl HSA conjugates were not used 
as a reference as done previously [2], since inhibi- 
tion varies slightly with the amount of penicilloyl 
groups present on HSA [7]. 
3. RESULTS AND DISCUSSION 
Fast albumin was isolated from the serum of a 
penicillin treated patient. Its cleavage with CNBr 
gave rise to three fragments analogous to the 
fragments obtained from normal albumin. They 
were named from the N- to the C-terminal ends: 
B1_rZj, C124_298 and A299_585. Furthermore, a por- 
tion of fast albumin and of its CNBr fragments 
were degraded by pronase, whereas another por- 
tion of the fragments was subjected to reduction 
(reduction of HSA was not performed, since it 
gives rise to insoluble material). All these 
materials, as well as PcAC, were examined on their 
capacity to inhibit the fixation of PAP to im- 
mobilized anti-penicilloyl antibodies. Fig. 1 shows 
the result of these experiments. 
Fast albumin proved to be a better inhibitor than 
any single fragment and inhibition was markedly 
increased by its degradation with pronase. The 
number of penicilloyl groups fixed to HSA was 
calculated from the amount of pronase-degraded 
HSA that gave 50% inhibition, using as a reference 
the amount of PcAC giving the same inhibition. 
The number of penicilloyl groups per molecule of 
HSA was found to be 0.9. . 
No inhibition was observed with fragment 
h-123, even after degradation by pronase or 
reduction of disulfide bonds. Fragment c124-298 
was inhibitory and this inhibition was greatly in- 
creased by degradation with pronase or by reduc- 
tion. Fragment A299-ss5 was inhibitory and 
Nonomoles of lnhlb,tor per assay 
Fig. 1. Plates were coated with anti-penicilloyl antibodies 
and allowed to react with a constant amount of PAP. 
Inhibition of this reaction by increasing amounts of 
inhibitors was studied. Inhibitors: fast albumin (a); 
fast albumin degraded by pronase (0); C (0); C 
degraded by pronase (0); C reduced (A); A (0); A 
degraded by pronase ( n ); A reduced (A); PEAC (*). The 
quantity of the latter inhibitor is expressed as nanomoles 
of penicilloyl groups. No inhibition was observed with 
normal albumin and its CNBr fragments. 
inhibition was also increased by degradation with 
pronase or by reduction but to a lesser extent than 
that observed with fragment Cr24_298. These ex- 
periments show clearly that fixation of penicilloyl 
grOUps OCCUrS Only to fragmentS c124-298 and 
A299-58s. 
It was previously shown [2,8] that penicilloyl 
groups are located on the albumin molecule mainly 
at sites which were not accessible to antibodies and 
are unmasked by enzymatic degradation. A similar 
observation was made with the CNBr fragments. 
In addition, the reduction was found to be still 
more effective in unmasking penicilloyl groups 
than enzymatic degradation, which suggests that 
the inaccessibility of penicilloyl groups is depen- 
dent upon the disulfide structure of the albumin 
molecule. Unmasking was less complete in the case 
of fragment A299-585 than of fragment c124-298 in- 
dicating that the penicilloyl site(s) is (are) more 
readily available on the native molecule in the 
former case. 
207 
Volume 220, number 1 FEBS LETTERS 
The maximum number of penicilloyl groups REFERENCES 
August 1987 
fixed per molecule of HSA was found to be close 
to one, in agreement with previous results using 
radioimmunoassay [2]. Since two sites for 
penicilloyl groups were demonstrated on HSA in 
the present paper, penicilloylated HSA should con- 
sist of several populations: molecules having non- 
fixed penicilloyl groups contaminating the fast 
one, molecules having fixed penicilloyl groups 
through one or the other of the two sites or 
through either site. This assumption is consistent 
with the electrophoretic heterogeneity of fast 
albumin [2]. 
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